论文部分内容阅读
尿激酶静脉溶栓治疗急性心肌梗塞(AMI)是目前简单、有效的方法。溶栓使梗塞相关的冠状动脉再通,在改善患者的心功能,提高其生存质量和生活质量方面的作用是勿容置疑,是影响心肌梗塞急性期及远期预后的重要因素。本研究旨在通过追加尿激酶的方法,提高AMI的延迟再通率,而不增加其并发症。1 研究对象与方法1.1 对象的选择与分组 自1993年1月至1998年6月对符合溶栓条件的AMI患者共选人264例,其中男176例,女88例,年龄39～83岁,平均58.7岁。按照临床AMI溶栓临床再通标准判断再通。溶栓后2小时再通165例,再通率为62.5％,
Intravenous thrombolysis of urokinase for acute myocardial infarction (AMI) is the simple and effective method. Thrombolysis to infarct-related coronary recanalization in improving the patient’s cardiac function and improve their quality of life and quality of life is beyond doubt, it is an important factor affecting the acute and long-term prognosis of myocardial infarction. The aim of this study was to increase the delayed recanalization of AMI by adding urokinase without increasing its complications. 1 Subjects and Methods 1.1 Object Selection and Grouping From January 1993 to June 1998, 264 patients with AMI who were eligible for thrombolytic therapy were enrolled, including 176 males and 88 females, aged 39-83 years. Average 58.7 years old. According to the clinical AMI thrombolytic clinical recanalization criteria to recanalize. Two hours after thrombolysis again in 165 cases, the recanalization rate was 62.5%